Good efficacy and safety of vedolizumab in Crohn's disease and ulcerative colitis in a real-world scenario.
Fabiana ZingoneBrigida BarberioFederico CompostellaGiulia GirardinRenata D'IncàCarla MarinelliIlaria MarsilioGreta LorenzonEdoardo Vincenzo SavarinoPublished in: Therapeutic advances in gastroenterology (2020)
Vedolizumab resulted in being effective and safe in CD as well as in UC patients.